Expression of ER-a36, a novel variant of estrogen receptor a, and resistance to tamoxifen treatment in breast cancer

被引：0
|
作者：
Shi, L.
Dong, B.
Li, Z.
Lu, Y.
Ouyang, T.
Li, J.
Wang, T.
Fan, Z.
Fan, T.
Lin, B.
Wang, Z.
Xie, Y.
机构：
[1] Peking Univ, Beijing 100871, Peoples R China
[2] Creighton Univ, Sch Med, Omaha, NE USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：216S / 216S
页数：1
相关论文
共 50 条
  • [41] Expression Significance of Estrogen Receptor ER-α36 in Breast Cancer Treated by Chemotherapy: A Meta-Analysis
    Enping He
    Xuliang Xia
    Hui Quan
    Ping Leng
    Molecular Biotechnology, 2024, 66 : 991 - 999
  • [42] Expression Significance of Estrogen Receptor ER-α36 in Breast Cancer Treated by Chemotherapy: A Meta-Analysis
    He, Enping
    Xia, Xuliang
    Quan, Hui
    Leng, Ping
    MOLECULAR BIOTECHNOLOGY, 2024, 66 (05) : 991 - 999
  • [43] Androgen receptor expression can predict benefit of tamoxifen treatment in patients with ER negative breast cancer
    Hilborn, Erik
    Gacic, Jelena
    Fornander, Tommy
    Skog, Lambert
    Nordenskjold, Bo
    Stal, Olle
    Jansson, Agneta
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [44] Tamoxifen and ERα36: Fertilizing the seeds of breast cancer metastasis
    Monika L. Burness
    Max S. Wicha
    Cell Research, 2018, 28 : 391 - 392
  • [45] Tamoxifen and ERα36: Fertilizing the seeds of breast cancer metastasis
    Burness, Monika L.
    Wicha, Max S.
    CELL RESEARCH, 2018, 28 (04) : 391 - 392
  • [46] Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen/aromatase inhibitors
    Mills, Jamie N.
    Rutkovsky, Alex C.
    Giordano, Antonio
    CURRENT OPINION IN PHARMACOLOGY, 2018, 41 : 59 - 65
  • [47] Selective human estrogen receptor partial agonist (ShERPAs) for treatment of tamoxifen-resistant ER plus breast cancer
    Delgado-Rivera, Loruhama M.
    CANCER RESEARCH, 2016, 76
  • [48] Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer
    Wang, Zhao-Yi
    Yin, Li
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 418 : 193 - 206
  • [49] USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
    Zhuang, Ting
    Zhang, Shuqing
    Liu, Dongyi
    Li, Zhongbo
    Li, Xin
    Li, Jiaoyan
    Yang, Penghe
    Zhang, Chenmiao
    Cui, Jiayao
    Fu, Mingxi
    Shen, Fangyu
    Yuan, Lei
    Zhang, Zhao
    Su, Peng
    Zhu, Jian
    Yang, Huijie
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [50] OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells
    Bhatt, S.
    Stender, J. D.
    Joshi, S.
    Wu, G.
    Katzenellenbogen, B. S.
    ONCOGENE, 2016, 35 (44) : 5722 - 5734
12345